China Bans Posing As Health Experts, Patients In Drug Commercials
This article was originally published in PharmAsia News
Executive SummaryChina has issued an edict banning certain types of broadcast advertising and non-professional hosts of medical programs. China's State FDA, Health Ministry and other affected agencies sent out a circular to radio and television stations detailing the ban. They said it was prompted by the discovery of one actor posing as a health expert on TV programs for the purpose of selling drugs while others posed as patients. The new ban bars those types of imitations and says actors and celebrities are not to host medical programs. (Click here for more
You may also be interested in...
Komipharm files for emergency clinical trial of its investigative drug to treat coronavirus pneumonia, which is poised to become the first such study by a Korean company.
Apple and Johnson & Johnson are recruiting patients into Heartline, a 150,000-patient "virtual" randomized study to evaluate how the Apple watch can improve patient outcomes by reducing risk of stroke and detect atrial fibrillation early. See what Heartline's co-chair Michael Gibson of Harvard University said about it here.
After eptinezumab’s approval in the US, EVP Peter Anastasiou told Scrip it will take time to change migraine doctors’ prescribing habits, but he expects CGRP inhibitors to become mainstay preventative treatments. Vyepti’s list price is about $1,000 below its competitors’ launch prices.